HC restrain Glenmark from selling anti-diabetes drugs
The Delhi High Court on Wednesday restrained Mumbai-based Glenmark Pharmaceuticals Ltd from making or selling its generic anti-diabetes drugs Zita and Zita-Met while holding it infringing patent of a US drug maker Merck, Sharp and Dohme Corporation.
Oct 07, 2015, 23:18 PM IST